Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.5000
+0.0050 (1.01%)
Sep 18, 2026, 1:20 PM AEST
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 14.72 million as of September 17, 2026. Its market cap has increased by 27.51% in one year.
Market Cap
14.72M
Enterprise Value
13.75M
Revenue
1.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
ChartMarket Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 14.72M, an increase of 84.70%. That is a compound annual growth rate of 28.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 14.72M | 36.32% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 22.99M |
| Argenica Therapeutics | 22.48M |
| Proteomics International Laboratories | 22.33M |
| EZZ Life Science Holdings | 20.47M |
| Algorae Pharmaceuticals | 18.25M |
| Neurotech International | 17.20M |
| Immuron | 14.21M |
| Ceryvyn Therapeutics | 13.68M |